Nifty
Sensex
:
:
25461.30
83442.50
0.30 (0.00%)
9.61 (0.01%)

Pharmaceuticals & Drugs - Domestic

Rating :
65/99

BSE: 531599 | NSE: FDC

489.40
04-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  488.75
  •  492.2
  •  485.25
  •  487.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  87185
  •  42583560.9
  •  658.85
  •  366.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,965.48
  • 29.86
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,912.82
  • N/A
  • 3.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.66%
  • 2.56%
  • 16.22%
  • FII
  • DII
  • Others
  • 2.56%
  • 6.25%
  • 2.75%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.13
  • 7.65
  • 8.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.48
  • 2.94
  • 5.94

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.50
  • 4.85
  • 12.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.23
  • 24.32
  • 25.95

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.91
  • 3.01
  • 3.04

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.26
  • 15.34
  • 17.07

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
18.58
16.39
P/E Ratio
26.34
29.86
Revenue
1935
2108
EBITDA
339
Net Income
305
267
ROA
12.7
P/B Ratio
3.80
ROE
14.96
FCFF
155
FCFF Yield
2.22
Net Debt
-455
BVPS
128.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
491.89
462.03
6.46%
464.11
458.17
1.30%
513.85
486.37
5.65%
638.27
536.38
19.00%
Expenses
437.91
405.71
7.94%
417.46
374.38
11.51%
443.69
409.94
8.23%
491.65
414.37
18.65%
EBITDA
53.98
56.33
-4.17%
46.65
83.79
-44.33%
70.16
76.42
-8.19%
146.62
122.00
20.18%
EBIDTM
10.97%
12.19%
10.05%
18.29%
13.65%
15.71%
22.97%
22.75%
Other Income
16.08
20.27
-20.67%
18.83
24.71
-23.80%
34.70
27.24
27.39%
28.44
29.42
-3.33%
Interest
1.19
0.95
25.26%
0.95
0.97
-2.06%
1.07
1.06
0.94%
1.30
1.05
23.81%
Depreciation
15.56
10.44
49.04%
13.36
9.97
34.00%
13.79
9.87
39.72%
11.02
9.63
14.43%
PBT
53.31
65.21
-18.25%
51.18
97.55
-47.53%
90.00
92.73
-2.94%
162.73
140.74
15.62%
Tax
14.64
18.93
-22.66%
14.14
18.37
-23.03%
17.96
22.94
-21.71%
43.70
30.93
41.29%
PAT
38.67
46.28
-16.44%
37.04
79.17
-53.21%
72.04
69.79
3.22%
119.04
109.81
8.41%
PATM
7.86%
10.02%
7.98%
17.28%
14.02%
14.35%
18.65%
20.47%
EPS
2.38
2.84
-16.20%
2.27
4.87
-53.39%
4.42
4.29
3.03%
7.31
6.62
10.42%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
2,108.12
1,942.94
1,783.75
1,527.92
1,333.20
1,344.19
1,090.70
1,075.07
1,013.87
994.32
889.31
Net Sales Growth
8.50%
8.92%
16.74%
14.61%
-0.82%
23.24%
1.45%
6.04%
1.97%
11.81%
 
Cost Of Goods Sold
736.28
656.15
655.79
530.21
414.07
425.72
345.14
352.08
339.05
357.93
272.91
Gross Profit
1,371.84
1,286.79
1,127.96
997.71
919.14
918.46
745.56
722.99
674.81
636.38
616.40
GP Margin
65.07%
66.23%
63.24%
65.30%
68.94%
68.33%
68.36%
67.25%
66.56%
64.00%
69.31%
Total Expenditure
1,790.71
1,604.41
1,534.16
1,274.23
999.15
1,051.25
859.68
848.38
770.40
765.58
690.76
Power & Fuel Cost
-
37.38
34.12
28.91
27.08
27.40
24.61
22.00
21.55
23.14
20.18
% Of Sales
-
1.92%
1.91%
1.89%
2.03%
2.04%
2.26%
2.05%
2.13%
2.33%
2.27%
Employee Cost
-
413.40
390.90
343.33
296.29
277.48
225.57
216.67
191.08
175.76
137.58
% Of Sales
-
21.28%
21.91%
22.47%
22.22%
20.64%
20.68%
20.15%
18.85%
17.68%
15.47%
Manufacturing Exp.
-
171.89
154.81
128.24
77.97
68.80
62.25
58.77
49.40
36.44
97.27
% Of Sales
-
8.85%
8.68%
8.39%
5.85%
5.12%
5.71%
5.47%
4.87%
3.66%
10.94%
General & Admin Exp.
-
107.33
101.01
70.29
55.64
58.06
59.45
61.55
53.35
49.97
41.43
% Of Sales
-
5.52%
5.66%
4.60%
4.17%
4.32%
5.45%
5.73%
5.26%
5.03%
4.66%
Selling & Distn. Exp.
-
187.19
171.01
147.96
87.74
94.70
78.92
75.96
64.36
57.73
64.96
% Of Sales
-
9.63%
9.59%
9.68%
6.58%
7.05%
7.24%
7.07%
6.35%
5.81%
7.30%
Miscellaneous Exp.
-
31.06
26.53
25.28
40.37
99.07
63.73
61.35
51.61
64.61
64.96
% Of Sales
-
1.60%
1.49%
1.65%
3.03%
7.37%
5.84%
5.71%
5.09%
6.50%
6.35%
EBITDA
317.41
338.53
249.59
253.69
334.05
292.94
231.02
226.69
243.47
228.74
198.55
EBITDA Margin
15.06%
17.42%
13.99%
16.60%
25.06%
21.79%
21.18%
21.09%
24.01%
23.00%
22.33%
Other Income
98.05
101.63
51.24
76.09
97.03
68.90
43.47
50.96
50.22
39.00
45.72
Interest
4.51
4.03
4.09
3.09
3.43
3.42
1.44
1.40
1.41
1.40
1.81
Depreciation
53.73
39.92
38.94
37.30
37.81
37.46
33.24
35.14
34.62
33.73
38.81
PBT
357.22
396.22
257.80
289.39
389.83
320.97
239.80
241.11
257.65
232.62
203.65
Tax
90.44
91.16
63.98
73.23
86.53
80.08
66.85
67.12
63.30
63.48
55.51
Tax Rate
25.32%
23.01%
24.82%
25.30%
22.32%
24.95%
28.01%
27.84%
25.14%
27.29%
27.26%
PAT
266.79
305.22
194.04
216.40
301.33
240.89
171.85
173.99
188.47
169.14
148.15
PAT before Minority Interest
266.79
305.06
193.83
216.16
301.18
240.89
171.85
173.99
188.47
169.14
148.15
Minority Interest
0.00
0.16
0.21
0.24
0.15
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.66%
15.71%
10.88%
14.16%
22.60%
17.92%
15.76%
16.18%
18.59%
17.01%
16.66%
PAT Growth
-12.54%
57.30%
-10.33%
-28.19%
25.09%
40.17%
-1.23%
-7.68%
11.43%
14.17%
 
EPS
16.39
18.75
11.92
13.29
18.51
14.80
10.56
10.69
11.58
10.39
9.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,097.17
1,982.05
1,956.79
1,734.13
1,547.43
1,445.24
1,276.11
1,270.20
1,082.47
936.38
Share Capital
16.28
16.59
16.88
16.88
17.10
17.52
17.52
17.86
17.86
17.86
Total Reserves
2,080.89
1,965.46
1,939.91
1,717.25
1,530.33
1,427.72
1,258.59
1,252.34
1,064.61
918.52
Non-Current Liabilities
604.16
468.64
391.17
299.63
314.62
229.17
211.41
216.67
19.93
24.06
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.25
0.56
0.65
0.72
0.34
0.49
0.60
0.69
0.79
0.90
Long Term Provisions
574.35
436.75
349.81
281.24
295.78
213.96
194.12
198.60
0.50
0.56
Current Liabilities
615.18
729.56
690.40
621.79
564.62
497.43
480.07
389.40
163.42
187.97
Trade Payables
186.03
178.49
136.94
77.28
117.86
77.61
97.32
75.10
82.59
87.17
Other Current Liabilities
101.50
96.59
86.44
77.36
80.06
61.67
68.78
64.11
50.16
36.61
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.00
Short Term Provisions
327.64
454.48
467.01
467.15
366.69
358.15
313.97
250.19
30.67
63.19
Total Liabilities
3,316.51
3,179.61
3,037.93
2,655.38
2,426.67
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
Net Block
680.26
698.92
705.06
689.15
673.50
682.19
673.64
678.05
675.16
393.04
Gross Block
987.18
973.27
949.42
897.55
844.97
817.80
776.49
745.84
708.81
629.67
Accumulated Depreciation
306.92
274.35
244.36
208.40
171.47
135.61
102.84
67.79
33.65
236.62
Non Current Assets
1,945.46
1,734.70
1,619.50
1,303.33
1,181.25
1,113.46
976.64
957.93
742.46
646.27
Capital Work in Progress
261.48
198.44
104.82
19.21
23.85
12.38
12.84
6.32
19.92
28.80
Non Current Investment
392.76
348.49
384.73
265.36
162.31
179.11
74.07
54.49
39.43
216.72
Long Term Loans & Adv.
609.51
487.41
424.05
326.65
320.83
239.08
215.28
218.46
7.70
6.37
Other Non Current Assets
1.45
1.45
0.84
2.96
0.75
0.71
0.81
0.60
0.25
1.33
Current Assets
1,367.05
1,443.06
1,418.43
1,352.05
1,245.41
1,058.38
990.94
918.34
523.36
502.13
Current Investments
450.03
457.29
500.77
524.84
502.24
405.93
397.16
436.53
285.41
272.49
Inventories
388.89
328.54
304.70
214.92
209.96
173.79
160.49
137.16
130.91
123.22
Sundry Debtors
117.38
122.65
82.17
110.54
123.74
87.53
81.66
76.06
61.94
61.04
Cash & Bank
26.29
24.94
38.66
31.58
32.32
21.26
29.30
28.47
18.02
14.95
Other Current Assets
384.46
9.94
11.70
19.76
377.15
369.88
322.33
240.12
27.10
30.44
Short Term Loans & Adv.
365.27
499.69
480.43
450.41
350.34
358.56
311.65
230.44
20.36
14.77
Net Current Assets
751.87
713.50
728.03
730.26
680.79
560.94
510.87
528.94
359.94
314.16
Total Assets
3,312.51
3,177.76
3,037.93
2,655.38
2,426.66
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
220.77
154.91
161.65
207.08
250.38
112.43
149.84
154.49
174.30
127.64
PBT
396.22
257.80
289.39
389.85
319.95
237.75
240.63
257.71
232.15
203.65
Adjustment
-51.18
4.32
-26.48
-48.34
22.58
-0.21
0.39
-10.88
2.41
-1.40
Changes in Working Capital
-20.35
-29.91
-21.72
-39.42
-7.77
-51.05
-23.24
-19.23
-4.54
-11.78
Cash after chg. in Working capital
324.69
232.21
241.19
302.09
334.77
186.49
217.78
227.60
230.02
190.48
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-103.92
-77.30
-79.54
-95.01
-84.39
-74.06
-67.94
-70.14
-55.73
-62.84
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.97
0.00
0.00
Cash From Investing Activity
-17.08
11.13
-144.57
-77.15
-98.35
-120.33
20.11
-143.55
-73.05
-88.57
Net Fixed Assets
-76.76
-123.01
-136.84
-45.20
-38.52
-40.93
-36.71
-24.24
-81.62
-169.89
Net Investments
-43.73
79.72
-95.30
-125.65
-79.51
-113.70
19.79
-166.18
170.44
-72.39
Others
103.41
54.42
87.57
93.70
19.68
34.30
37.03
46.87
-161.87
153.71
Cash from Financing Activity
-202.16
-179.95
-9.84
-129.35
-142.00
-0.07
-169.43
0.35
-96.98
-47.76
Net Cash Inflow / Outflow
1.53
-13.90
7.25
0.58
10.03
-7.96
0.52
11.29
4.27
-8.69
Opening Cash & Equivalents
23.89
37.73
30.43
29.88
19.92
28.13
27.10
16.25
12.17
23.26
Closing Cash & Equivalent
25.42
23.89
37.73
30.43
29.88
19.92
28.13
27.10
16.25
14.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
128.81
119.47
115.92
102.73
90.51
82.86
73.17
71.42
60.87
52.62
ROA
9.39%
6.23%
7.59%
11.85%
10.48%
8.30%
9.05%
12.00%
14.01%
13.34%
ROE
14.96%
9.84%
11.71%
18.36%
16.10%
12.63%
13.67%
16.02%
16.76%
16.64%
ROCE
19.62%
13.27%
15.78%
23.74%
21.63%
17.64%
19.04%
21.51%
23.15%
23.02%
Fixed Asset Turnover
2.04
1.91
1.70
1.57
1.66
1.41
1.42
1.44
1.52
1.65
Receivable days
21.91
20.32
22.35
31.31
27.96
27.55
26.58
23.96
22.06
24.19
Inventory Days
65.48
62.83
60.27
56.79
50.80
54.43
50.15
46.55
45.58
45.45
Payable days
101.39
87.78
73.73
86.01
38.19
40.35
41.32
40.83
44.81
47.89
Cash Conversion Cycle
-14.00
-4.62
8.89
2.09
40.57
41.62
35.41
29.68
22.84
21.74
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
99.22
64.07
94.67
113.90
94.95
166.95
172.62
179.60
167.11
113.30

News Update:


  • FDC recalling 60,428 bottles of Timolol Maleate Ophthalmic Solution in US market
    12th May 2025, 12:44 PM

    The drugmaker initiated the Class II nationwide (US) recall on April 18, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.